From GlobeNewswire: 2025-06-02 09:30:00

The global Drug Delivery Systems Market was valued at USD 43.91 billion in 2024 and is projected to reach USD 68.86 billion by 2032, with a CAGR of 5.86%. Factors driving growth include increasing chronic ailments, technological advancements, and demand for self-administration of medication. New technologies are enhancing therapeutic effectiveness and patient compliance, leading to market adoption worldwide.

In the U.S., the market contributed USD 14.84 billion in 2024 and is expected to reach USD 22.89 billion by 2032, with a CAGR of 5.64%. North America remains a key region due to its strong health infrastructure, R&D presence, and regulatory frameworks. The region’s innovative drug delivery forms and major pharma companies further solidify its leading position.

Injectables lead the market with a 58.14% share in 2024, particularly in hospital settings for medications like biologics and insulin. Traditional drug delivery devices, like oral tablets and syringes, hold a 76.2% market share due to ease of use and proven efficacy. Retail pharmacies are poised for significant growth, driven by consumer demand for self-administered treatments for chronic diseases.

North America is the leading market for drug delivery systems, driven by technology adoption and robust reimbursement systems. The Asia-Pacific region is expected to see rapid growth by 2032, fueled by increased healthcare spending and adoption of novel delivery models. Major players in the market include Johnson & Johnson, Pfizer, and 3M Company.

For more in-depth analysis and insights into the Drug Delivery Systems Market, visit https://www.snsinsider.com/checkout/3023. The market report covers key segments, market size projections, and regional insights, providing a comprehensive overview of the industry. With growing demand for innovative drug delivery solutions, the market is set for continued growth and development.



Read more at GlobeNewswire: Drug Delivery Systems Market to Hit USD 68.86 Billion by